Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer
Susana R�os, Alan J. Wright, Paula D’Santos, et al.
Cancer Cell (2020) Vol. 38, Iss. 4, pp. 516-533.e9
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer
Le Yu, Jessica Wei, Pengda Liu
Seminars in Cancer Biology (2021) Vol. 85, pp. 69-94
Closed Access | Times Cited: 385
PI3K inhibitors are finally coming of age
Bart Vanhaesebroeck, Matthew W. D. Perry, Jennifer R. Brown, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 10, pp. 741-769
Open Access | Times Cited: 337
The present and future of PI3K inhibitors for cancer therapy
Pau Castel, Eneda Toska, Jeffrey A. Engelman, et al.
Nature Cancer (2021) Vol. 2, Iss. 6, pp. 587-597
Open Access | Times Cited: 124
At a crossroads: how to translate the roles of PI3K in oncogenic and metabolic signalling into improvements in cancer therapy
Neil Vasan, Lewis C. Cantley
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 7, pp. 471-485
Open Access | Times Cited: 112
Metabolic analysis as a driver for discovery, diagnosis, and therapy
Ralph J. DeBerardinis, Kayvan R. Keshari
Cell (2022) Vol. 185, Iss. 15, pp. 2678-2689
Open Access | Times Cited: 99
Molecular and functional imaging in cancer-targeted therapy: current applications and future directions
Jing‐Wen Bai, Si-Qi Qiu, Guo‐Jun Zhang
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 93
YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner
Hengyu Chen, Yuanhang Yu, Ming Yang, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 78
Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling
Roberto Würth, Elisa Donato, Laura L. Michel, et al.
Nature Cancer (2025)
Open Access | Times Cited: 3
Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity
Sarah Christine Elisabeth Wright, Natali Vasilevski, Violeta Serra, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1538-1538
Open Access | Times Cited: 68
Glycolysis-related lncRNA TMEM105 upregulates LDHA to facilitate breast cancer liver metastasis via sponging miR-1208
Jinzhu Han, Xuyi Chen, Jianlong Wang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 21
Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance
Lei Pan, Wenzhou Wang, Marisela Sheldon, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3390-3390
Open Access | Times Cited: 21
Imaging cancer metabolism using magnetic resonance
Kevin M. Brindle
npj Imaging (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 6
Transcriptional Repression by FoxM1 Suppresses Tumor Differentiation and Promotes Metastasis of Breast Cancer
Dragana Kopanja, Vaibhav Chand, Eilidh O'Brien, et al.
Cancer Research (2022) Vol. 82, Iss. 13, pp. 2458-2471
Open Access | Times Cited: 27
New Horizons in Hyperpolarized 13C MRI
Myriam M. Chaumeil, James A. Bankson, Kevin M. Brindle, et al.
Molecular Imaging and Biology (2023) Vol. 26, Iss. 2, pp. 222-232
Open Access | Times Cited: 13
Hyperpolarized MRI, functional MRI, MR spectroscopy and CEST to provide metabolic information in vivo
Peter C.M. van Zijl, Kevin M. Brindle, Hanzhang Lu, et al.
Current Opinion in Chemical Biology (2021) Vol. 63, pp. 209-218
Open Access | Times Cited: 27
A narrative review of research progress on FoxM1 in breast cancer carcinogenesis and therapeutics
Yanling Zhang, Yan Ma, Youqin Zeng, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 22, pp. 1704-1704
Open Access | Times Cited: 27
USP39 facilitates breast cancer cell proliferation through stabilization of FOXM1.
Zhenwang Zhang, Wu Liu, Xiajun Bao, et al.
PubMed (2022) Vol. 12, Iss. 8, pp. 3644-3661
Closed Access | Times Cited: 21
Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models
Lorna Hopcroft, Eleanor M. Wigmore, Stuart C. Williamson, et al.
npj Breast Cancer (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Metabolic Reprogramming and Adaption in Breast Cancer Progression and Metastasis
Qianying Zuo, Yibin Kang
Advances in experimental medicine and biology (2025), pp. 347-370
Closed Access
The interplay between FOXO3 and FOXM1 influences sensitivity to AKT inhibition in PIK3CA and PIK3CA/PTEN altered estrogen receptor positive breast cancer
Valentina Cutano, Ming Li Chia, Eleanor M. Wigmore, et al.
npj Breast Cancer (2025) Vol. 11, Iss. 1
Open Access
Hyperpolarized Carbon-13 MRI for Early Response Assessment of Neoadjuvant Chemotherapy in Breast Cancer Patients
Ramona Woitek, Mary A. McLean, Stephan Ursprung, et al.
Cancer Research (2021) Vol. 81, Iss. 23, pp. 6004-6017
Open Access | Times Cited: 24
AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors
Shanade Dunn, Cath Eberlein, Jason Yu, et al.
Oncogene (2022) Vol. 41, Iss. 46, pp. 5046-5060
Open Access | Times Cited: 17
Tumor heterogeneity and clinically invisible micrometastases in metastatic breast cancer—a call for enhanced surveillance strategies
Eliza R. Bacon, Kena Ihle, Weihua Guo, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 3
Imaging Glioblastoma Response to Radiotherapy Using 2H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
Friederike Hesse, Alan J. Wright, Vencel Somai, et al.
Cancer Research (2022) Vol. 82, Iss. 19, pp. 3622-3633
Open Access | Times Cited: 14
Integrating metabolic reprogramming and metabolic imaging to predict breast cancer therapeutic responses
Yi Liu, Qian Zhou, Shaoli Song, et al.
Trends in Endocrinology and Metabolism (2021) Vol. 32, Iss. 10, pp. 762-775
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top